James Collins, Ph.D.
Jim Collins is an institute member of the Broad Institute of MIT and Harvard. He is also the Termeer Professor of Medical Engineering & Science and a professor of biological engineering at MIT, as well as a member of the Harvard-MIT Health Sciences & Technology faculty. He is also a core founding faculty member of the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Collins is one of the founders of the field of synthetic biology, and his research group is currently focused on using synthetic biology to create next-generation diagnostics and therapeutics. Collins' patented technologies have been licensed by over 25 biotech, pharma, and medical devices companies, and he has co-founded a number of companies, including Synlogic, Senti Biosciences, Sherlock Biosciences, and Cellarity, as well as Phare Bio, a non-profit focused on AI-driven antibiotic discovery.
Collins has received numerous awards and honors, including a Rhodes Scholarship and a MacArthur "Genius" Award, and he is an elected member of all three national academies: the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine.